Suzhou Zelgen Biopharmaceuticals Co.,ltd

This study is testing a new drug called ZGGS34 in people with advanced solid tumors that have not responded to standard treatments. The first part will find a safe dose, and the second part will see if the drug, sometimes given with chemotherapy, can help control cancer in people…

This early-stage study aims to check the safety of a new drug called ZG006 when given alongside standard immunotherapy drugs for people with extensive small-cell lung cancer. It will involve about 100 adults who have not yet received treatment for this aggressive cancer. The main…